Apex Biotechnology Corp (1733) — Working Capital to Net Assets Ratio
Apex Biotechnology Corp (1733) has a Working Capital to Net Assets ratio of 65.2% as of September 2025. Working capital of NT$1.18 Billion (current assets of NT$1.57 Billion minus current liabilities of NT$383.92 Million) is measured against net assets of NT$1.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Apex Biotechnology Corp to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apex Biotechnology Corp Working Capital to Net Assets (2009–2024)
This chart shows how Apex Biotechnology Corp's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 65.2%, reflecting working capital of NT$1.18 Billion against net assets of NT$1.81 Billion TWD. See defensive interval ratio of Apex Biotechnology Corp to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Apex Biotechnology Corp (2009–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apex Biotechnology Corp from 2009 to 2024, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 1733 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 63.9% | NT$1.17 Billion | NT$1.82 Billion | NT$1.64 Billion | NT$477.77 Million | ▲ +1.4 pp |
| 2023 | 62.5% | NT$1.12 Billion | NT$1.80 Billion | NT$1.51 Billion | NT$383.35 Million | ▲ +2.9 pp |
| 2022 | 59.6% | NT$1.08 Billion | NT$1.82 Billion | NT$1.65 Billion | NT$570.55 Million | ▲ +4.1 pp |
| 2021 | 55.5% | NT$973.97 Million | NT$1.75 Billion | NT$1.76 Billion | NT$785.89 Million | ▲ +6.9 pp |
| 2020 | 48.7% | NT$801.05 Million | NT$1.65 Billion | NT$1.68 Billion | NT$883.43 Million | ▼ -20.3 pp |
| 2019 | 69.0% | NT$1.16 Billion | NT$1.68 Billion | NT$1.78 Billion | NT$621.28 Million | ▲ +3.2 pp |
| 2018 | 65.7% | NT$1.08 Billion | NT$1.64 Billion | NT$1.58 Billion | NT$501.67 Million | ▲ +30.9 pp |
| 2017 | 34.9% | NT$580.26 Million | NT$1.66 Billion | NT$1.60 Billion | NT$1.02 Billion | ▼ -33.7 pp |
| 2016 | 68.6% | NT$1.19 Billion | NT$1.73 Billion | NT$1.60 Billion | NT$414.57 Million | ▲ +7.3 pp |
| 2015 | 61.3% | NT$1.18 Billion | NT$1.93 Billion | NT$1.58 Billion | NT$392.60 Million | ▲ +24.9 pp |
| 2014 | 36.4% | NT$679.72 Million | NT$1.87 Billion | NT$1.43 Billion | NT$752.29 Million | ▼ -19.0 pp |
| 2013 | 55.4% | NT$1.06 Billion | NT$1.92 Billion | NT$1.45 Billion | NT$383.35 Million | ▼ -18.4 pp |
| 2012 | 73.8% | NT$1.49 Billion | NT$2.01 Billion | NT$1.82 Billion | NT$332.53 Million | ▲ +7.3 pp |
| 2011 | 66.5% | NT$1.16 Billion | NT$1.75 Billion | NT$1.53 Billion | NT$368.30 Million | ▲ +2.7 pp |
| 2010 | 63.8% | NT$1.04 Billion | NT$1.63 Billion | NT$1.34 Billion | NT$302.11 Million | ▼ -2.2 pp |
| 2009 | 66.0% | NT$970.86 Million | NT$1.47 Billion | NT$1.26 Billion | NT$284.30 Million | — |